Projects funded by the NCN
Determination of arginase-1 as a potential drug target in the treatment of multiple myeloma and in reducing proteasome inhibitor-mediated cardiotoxicity
2017/25/B/NZ6/01139
Keywords:
aginase proteasome multiple myeloma cardiotoxicity immune response
Descriptors:
- NZ5_7: Human disease treatment
- NZ4_4: Pathophysiology
- NZ6_1: Adaptive and innate immunity
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 952 100 PLN
Project start date (Y-m-d): 2018-01-24
Project end date (Y-m-d): 2022-07-23
Project duration:: 54 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.